GLP-1 and Fertility: What Women Need to Know Before Starting

If you're considering GLP-1 medications like Semaglutide or Tirzepatide for weight management, understanding how these treatments affect fertility and pregnancy is essential. While GLP-1 receptor agonists offer powerful benefits for metabolic health, they come with important considerations for women of reproductive age.

Whether you're actively trying to conceive, might become pregnant, or simply want to understand the full picture before starting treatment, this guide covers what you need to know about GLP-1 and fertility.

How GLP-1 Medications Can Affect Fertility

One of the lesser-known effects of GLP-1 therapy is its potential impact on fertility—particularly for women with polycystic ovary syndrome (PCOS) or those carrying excess weight.

Weight loss achieved through GLP-1 medications can actually improve fertility in women who have struggled with ovulation due to obesity or insulin resistance. As your body composition changes and insulin sensitivity improves, hormonal balance often shifts, potentially restoring regular ovulation cycles.

This means that women who haven't been ovulating regularly—or at all—may find themselves fertile again while on GLP-1 therapy. If you're not planning a pregnancy, this makes reliable contraception more important than ever.

GLP-1 Use During Pregnancy: What the Research Shows

Currently, GLP-1 medications are not recommended during pregnancy. While research in humans is limited, animal studies have shown potential risks to fetal development. The manufacturers of both Semaglutide and Tirzepatide advise discontinuing these medications before conception.

The standard recommendation is to stop GLP-1 therapy at least two months before trying to conceive. This waiting period allows the medication to clear your system completely, as these drugs have extended half-lives that keep them active in your body for weeks after your last dose.

If you discover you're pregnant while taking a GLP-1 medication, contact your healthcare provider immediately. They'll help you safely discontinue the medication and develop an appropriate plan for your pregnancy.

Birth Control Considerations While on GLP-1 Therapy

Here's something many women don't realize: GLP-1 medications can affect how your body absorbs oral contraceptives.

Because GLP-1s slow gastric emptying—meaning food and medications move more slowly through your digestive system—there's concern that oral birth control pills may not be absorbed as effectively, particularly during the first few weeks of treatment or after dose increases.

If you're using oral contraceptives and don't want to become pregnant, consider these precautions:

• Use backup contraception (like condoms) for at least four weeks after starting GLP-1 therapy
• Continue backup methods for four weeks after any dose increase
• Consider switching to non-oral contraception methods like IUDs, implants, or injections that don't rely on gastrointestinal absorption
• Discuss your specific situation with your healthcare provider

Planning for Pregnancy While Using GLP-1s

If you're interested in GLP-1 therapy but know you want to become pregnant in the near future, timing matters.

The good news: many women find that the metabolic improvements and weight loss achieved through GLP-1 therapy can improve their fertility and pregnancy outcomes in the long term. Entering pregnancy at a healthier weight reduces risks of gestational diabetes, preeclampsia, and other complications.

The key is planning ahead. Work with your healthcare provider to:

• Set realistic weight loss goals before conception
• Time your treatment to allow for the recommended two-month washout period
• Transition to pregnancy-safe strategies for maintaining your weight loss
• Optimize your overall metabolic health before trying to conceive

Some women choose to complete a course of GLP-1 therapy, discontinue the medication, maintain their weight loss through lifestyle changes, and then pursue pregnancy from a healthier starting point.

What About Breastfeeding?

Information about GLP-1 medications and breastfeeding is also limited. It's unknown whether Semaglutide or Tirzepatide pass into breast milk or what effects they might have on nursing infants.

For this reason, most healthcare providers recommend against using GLP-1 medications while breastfeeding. If you're nursing or planning to breastfeed, discuss alternative weight management strategies with your provider.

Questions to Ask Your Provider

Before starting GLP-1 therapy, have an open conversation with your healthcare provider about your reproductive plans. Come prepared with questions like:

• Given my current fertility status, what precautions should I take?
• What's the best contraception method for me while on this medication?
• If I want to become pregnant in the next year or two, is now the right time to start?
• How will we monitor for unintended pregnancy during treatment?
• What's the plan if I do become pregnant while taking this medication?

For more information about GLP-1 therapy and women's health, visit ozarihealth.com/blog for additional resources.

Key Takeaways

• GLP-1 medications can improve fertility in women with PCOS or obesity-related ovulation issues, making effective contraception essential if you're not planning pregnancy
• Stop GLP-1 therapy at least two months before trying to conceive, as these medications are not recommended during pregnancy or breastfeeding
• Oral contraceptives may be less effective when starting GLP-1s due to delayed gastric emptying—use backup contraception or consider non-oral methods
• Strategic timing can optimize outcomes—many women benefit from completing GLP-1 therapy, achieving their health goals, then transitioning to pregnancy from a healthier metabolic baseline

Frequently Asked Questions

Can I take Semaglutide or Tirzepatide if I have PCOS and want to improve my fertility?

Yes, GLP-1 medications may actually help improve fertility in women with PCOS by promoting weight loss and improving insulin sensitivity. However, you should not be actively trying to conceive while taking these medications. Many women use GLP-1 therapy to improve their metabolic health first, then discontinue the medication for at least two months before trying to get pregnant. Always work with your healthcare provider to create a timeline that's right for your situation.

What should I do if I accidentally get pregnant while taking a GLP-1 medication?

Contact your healthcare provider immediately if you discover you're pregnant while on Semaglutide or Tirzepatide. They'll advise you to stop the medication right away and will monitor your pregnancy appropriately. While this isn't an ideal situation, don't panic—your provider will help ensure you receive proper prenatal care. This is exactly why reliable contraception is so important for women of reproductive age taking GLP-1 medications.

How long after stopping GLP-1 therapy can I safely try to conceive?

The standard recommendation is to wait at least two months after your last dose before trying to conceive. This allows time for the medication to completely clear your system. Both Semaglutide and Tirzepatide have long half-lives, meaning they remain active in your body for an extended period. Your healthcare provider may recommend a specific timeline based on your dosage and individual circumstances.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.